Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review

JAMA Cardiology

Volumn 3, Issue 10, 2018, Pages 1011-1019

  Tahhan, Ayman Samman ^a   Vaduganathan, Muthiah ^b   Greene, Stephen J ^c   Fonarow, Gregg C ^d,e   Fiuzat, Mona ^c   Jessup, Mariell ^f   Lindenfeld, Joann ^g   O'Connor, Christopher M ^h   Butler, Javed ⁱ  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JAMA   (United States)

^f Fondation Leducq   (France)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h INOVA HEART AND VASCULAR INSTITUTE   (United States)

ⁱ UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; CLINICAL TRIAL (TOPIC); EPIDEMIOLOGY; ETHNIC GROUP; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; RESEARCH SUBJECT; REVIEW; SYSTEMATIC REVIEW; TREND STUDY; COMPARATIVE STUDY; ETHICS; ETHNOLOGY; HEART STROKE VOLUME; MIDDLE AGED; PATIENT SELECTION;

AGE FACTORS; AGED; CLINICAL TRIALS AS TOPIC; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MIDDLE AGED; PATIENT SELECTION; STROKE VOLUME;

EID: 85052944853     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2018.2559     Document Type: Review

References (29)

1. Yancy CW. Heart failure in African Americans. Am J Cardiol. 2005; 96 (7B): 3i-12i. 16226931
2. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002; 40 (5): 976-982. 12225726
3. Bajaj NS, Gutiérrez OM, Arora G, Racial differences in plasma levels of N-terminal pro-B-type natriuretic peptide and outcomes: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018; 3 (1): 11-17. 29167879
4. McNamara DM, Taylor AL, Tam SW, G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT. JACC Heart Fail. 2014; 2 (6): 551-557. 25306451
5. Vaduganathan M, Butler J, Gheorghiade M. Transforming drug development in heart failure: navigating the regulatory crossroads. Circ Heart Fail. 2016; 9 (10): 9. 27707750
6. Health NIo. NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. Amended October 2001. https://grants.nih.gov/grants/funding/women-min/guidelines.htm. Accessed July 14, 2018.
7. Smith JG, Avery CL, Evans DS,; CARe and COGENT consortia. Impact of ancestry and common genetic variants on QT interval in African Americans. Circ Cardiovasc Genet. 2012; 5 (6): 647-655. 23166209
8. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002; 162 (15): 1682-1688. 12153370
9. Fonarow GC, Stough WG, Abraham WT,; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007; 50 (8): 768-777. 17707182
10. Steinberg BA, Zhao X, Heidenreich PA,; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012; 126 (1): 65-75. 22615345
11. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, Committee ASA; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006; 47 (1): 76-84. 16386668
12. Fonarow GC, Albert NM, Curtis AB, Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010; 122 (6): 585-596. 20660805
13. Khariton Y, Hernandez AF, Fonarow GC, Health status variation across practices in outpatients with heart failure: insights from the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry. Circ Cardiovasc Qual Outcomes. 2018; 11 (4): e004668. 29627798
14. Gerber Y, Weston SA, Redfield MM, A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015; 175 (6): 996-1004. 25895156
15. Gottdiener JS, McClelland RL, Marshall R, Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function: the Cardiovascular Health Study. Ann Intern Med. 2002; 137 (8): 631-639. 12379062
16. Lee DS, Gona P, Vasan RS, Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009; 119 (24): 3070-3077. 19506115
17. Silverman MG, Patel B, Blankstein R, Impact of race, ethnicity, and multimodality biomarkers on the incidence of new-onset heart failure with preserved ejection fraction (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2016; 117 (9): 1474-1481. 27001449
18. Adams KF Jr, Fonarow GC, Emerman CL,; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149 (2): 209-216. 15846257
19. Patel HC, Hayward C, Dungu JN, Assessing the eligibility criteria in phase iii randomized controlled trials of drug therapy in heart failure with preserved ejection fraction: the critical play-off between a "pure" patient phenotype and the generalizability of trial findings. J Card Fail. 2017; 23 (7): 517-524. 28434933
20. Sullivan LT, Randolph T, Merrill P, Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction. Am Heart J. 2018; 197: 43-52. 29447783
21. Vitale C, Fini M, Spoletini I, Lainscak M, Seferovic P, Rosano GM. Under-representation of elderly and women in clinical trials. Int J Cardiol. 2017; 232: 216-221. 28111054
22. Franceschini N, Fox E, Zhang Z,; Asian Genetic Epidemiology Network Consortium. Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet. 2013; 93 (3): 545-554. 23972371
23. Thomas KL, Hernandez AF, Dai D, Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. Am Heart J. 2011; 161 (4): 746-754. 21473975
24. Melloni C, Berger JS, Wang TY, Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010; 3 (2): 135-142. 20160159
25. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2000; 343 (7): 475-480. 10944565
26. Zhang T, Tsang W, Wijeysundera HC, Ko DT. Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. Am Heart J. 2013; 166 (1): 52-57. 23816021
27. Vaduganathan M, Samman Tahhan A, Greene SJ, Okafor M, Kumar S, Butler J. Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years. Eur J Heart Fail. 2018; 20 (6): 1068-1071. 29314445
28. Samman Tahhan A, Vaduganathan M, Greene SJ, Okafor M, Kumar S, Butler J. Evolving landscape of clinical trials in heart failure: patient populations, endpoint selection, and regions of enrollment. Curr Heart Fail Rep. 2018; 15 (1): 10-16. 29350324
29. Ramsey TM, Snyder JK, Lovato LC,; SPRINT Study Research Group. Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial. Clin Trials. 2016; 13 (3): 319-330. 26911833